JPRN-jRCT2031220092已完成1 期
A single-dose study of HP-6050
Inakura Hiroshi0 个研究点目标入组 16 人开始时间: 2022年5月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 < 40age old（—）
- 性别
- All
入选标准
- •Healthy Japanese adult males and females aged >=18 and <40 years
- •- Body mass index (BMI) is >=18.5 and <25.0
排除标准
- •- Subjects with vagal tone
- •- Subjects with current or history of serious cardiac, vascular, renal, hepatic, psychiatric/neurological, or metabolic diseases
- •- Subjects who received any drug within a week prior to application of the study drug
研究者
相似试验
已完成
1 期
Pharmacokinetic study of HP-6050Healthy adult and elderlyJPRN-jRCT2031220536Inakura Hiroshi60
未知
1 期
Phase I/II study of HP-3060 in patients with allergic rhinitis.Allergic rhinitisJPRN-jRCT2080222141Hisamitsu Pharmaceutical Co., Inc.
已完成
2 期
Single dose pharmacokinetic study of HP-3060Allergic rhinitisJPRN-jRCT2080223788Hisamitsu Pharmaceutical Co., Inc.24
未知
2 期
Single dose pharmacokinetic study of HP-3060Allergic rhinitisJPRN-jRCT2080223009Hisamitsu Pharmaceutical Co., Inc.
未知
1 期
ONO-6950 Phase 1 StudyAsthmaJPRN-jRCT2080221601ONO PHARMACEUTICAL CO.,LTD.52